Status:
COMPLETED
Schizophrenia Treatment With Photoneuromodulation
Lead Sponsor:
University of Sao Paulo
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
Abstract: Randomized clinical trial that aims to see the efficacy of photoneuromodulation for the treatment of negative symptoms of schizophrenia in patients refractory to transcranial direct current ...
Eligibility Criteria
Inclusion
- Patients between 18 and 55 years
- Diagnosis of schizophrenia according to DSM-IV criteria and confirmed by the SCID (Structured Clinical Interview for DSMIV), which will be applied by a psychiatrist, will be included.
- Minimum score of 20 points in the sum of negative PANSS
- Stable antipsychotic medications
- There is a need for at least one trial with at least one antipsychotic in adequate dose and time to enter the study.
Exclusion
- Unstable or uncontrolled clinical diseases,
- Psychiatric comorbidities,
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05339347
Start Date
August 1 2021
End Date
March 11 2022
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo
São Paulo, São Paulo, Brazil